Christian Camani

Christian Camani is an experienced investor with a diverse portfolio spanning multiple companies, including Turn2X, Veesion, ONWARD, PathoQuest, Threatray, Attolight, AVAtronics, Biograil™, Wildbiene + Partner, and InterAx Biotech, all of which Christian has been associated with since various dates from 2017 to 2023. In addition to a successful investment career, Christian Camani holds a Master of Business Administration (MBA) from the University of St.Gallen, where studies were completed from 1987 to 1992.